NeuroBo Pharmaceuticals Inc (NRBO)
3.36
+0.13
(+4.02%)
USD |
NASDAQ |
Apr 30, 16:00
3.36
0.00 (0.00%)
After-Hours: 17:59
NeuroBo Pharmaceuticals Cash from Investing (Quarterly): -0.009M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.009M |
| September 30, 2023 | -0.037M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.004M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.008M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.583M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.003M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.071M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.002M |
| December 31, 2019 | -5.939M |
| September 30, 2019 | -0.093M |
| Date | Value |
|---|---|
| June 30, 2019 | -0.025M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.003M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.939M
Minimum
Dec 2019
0.071M
Maximum
Dec 2020
-0.3482M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Conmed Corp | -2.035M |
| Eli Lilly and Co | -2.924B |
| Vanda Pharmaceuticals Inc | -43.78M |
| Alaunos Therapeutics Inc | 1.503M |
| Relmada Therapeutics Inc | 7.741M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.393M |
| Free Cash Flow | -10.85M |
| Free Cash Flow Per Share (Quarterly) | -0.6683 |
| Free Cash Flow Yield | -63.67% |